GB9818914D0 - Use - Google Patents

Use

Info

Publication number
GB9818914D0
GB9818914D0 GBGB9818914.5A GB9818914A GB9818914D0 GB 9818914 D0 GB9818914 D0 GB 9818914D0 GB 9818914 A GB9818914 A GB 9818914A GB 9818914 D0 GB9818914 D0 GB 9818914D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9818914.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9818914.5A priority Critical patent/GB9818914D0/en
Publication of GB9818914D0 publication Critical patent/GB9818914D0/en
Priority to AU59706/99A priority patent/AU5970699A/en
Priority to PCT/EP1999/006219 priority patent/WO2000012623A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
GBGB9818914.5A 1998-08-28 1998-08-28 Use Ceased GB9818914D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9818914.5A GB9818914D0 (en) 1998-08-28 1998-08-28 Use
AU59706/99A AU5970699A (en) 1998-08-28 1999-08-25 Use
PCT/EP1999/006219 WO2000012623A2 (en) 1998-08-28 1999-08-25 Use of 5-th receptor antagonists for the treatment of parkinson's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9818914.5A GB9818914D0 (en) 1998-08-28 1998-08-28 Use

Publications (1)

Publication Number Publication Date
GB9818914D0 true GB9818914D0 (en) 1998-10-21

Family

ID=10838073

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9818914.5A Ceased GB9818914D0 (en) 1998-08-28 1998-08-28 Use

Country Status (3)

Country Link
AU (1) AU5970699A (en)
GB (1) GB9818914D0 (en)
WO (1) WO2000012623A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041691B1 (en) 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
PE20020063A1 (en) 2000-06-20 2002-01-30 Upjohn Co BIS-ARYLSULFONES AS LIGANDS OF THE 5-HT RECEPTOR
US6586592B2 (en) 2000-06-20 2003-07-01 Pharmacia & Upjohn Company Bis-arylsulfones
US7071220B2 (en) 2000-09-18 2006-07-04 Toa Eiyo Ltd. N-substituted benzothiophenesulfonamide derivatives
DE60142914D1 (en) * 2000-09-18 2010-10-07 Toa Eiyo Ltd N-SUBSTITUTED BENZOTHIOPHENESULFONAMIDE DERIVATIVES
EP1353914A2 (en) 2001-01-16 2003-10-22 AstraZeneca AB Therapeutic chromone compounds
NZ526697A (en) 2001-01-16 2005-05-27 Astrazeneca Ab Therapeutic heterocyclic compounds
CA2443724C (en) * 2001-05-11 2009-11-03 Patrizia Caldirola Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
US7718650B2 (en) 2001-05-11 2010-05-18 Biovitrum Ab Aryl sulfonamide compounds for treating obesity
AU2002340804B2 (en) 2001-08-10 2008-04-03 F. Hoffmann-La Roche Ag Arylsulfonyl derivatives with 5-HT6 receptor affinity
DE60333351D1 (en) * 2002-03-15 2010-08-26 Toa Eiyo Ltd N-SUBSTITUTED BENZOTHIOPHENESULFONAMID DERIVATIVE
PA8802201A1 (en) 2007-11-02 2009-06-23 Abbott Gmbh & Co Kg APPROPRIATE BENCENSULFONALIDE COMPOUNDS TO TREAT DISORDERS THAT RESPOND TO THE MODULATION OF SEROTONINE 5-HT6 RECEPTOR
NZ592685A (en) 2008-10-23 2013-04-26 Vertex Pharma Modulators of cystic fibrosis transmembrane conductance regulator
US8343959B2 (en) 2009-04-30 2013-01-01 Abbott Gmbh & Co. Kg N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
US8362010B2 (en) 2009-04-30 2013-01-29 Abbott Gmbh & Co. Kg Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
SG175187A1 (en) 2009-04-30 2011-11-28 Abbott Gmbh & Co Kg N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
CA2759491A1 (en) * 2009-04-30 2010-11-04 Abbott Gmbh & Co. Kg. Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
WO2012059432A1 (en) 2010-11-01 2012-05-10 Abbott Gmbh & Co. Kg N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
WO2012059431A1 (en) 2010-11-01 2012-05-10 Abbott Gmbh & Co. Kg Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
MX2016005348A (en) * 2013-10-25 2016-08-11 Glaxosmithkline Llc Novel compounds.
JP6992004B2 (en) 2016-04-26 2022-02-03 ハー・ルンドベック・アクチエゼルスカベット Use of Acetylcholinesterase Inhibitors and Idalopyrdin to Reduce Falls in Patients with Parkinson's Disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
US5939451A (en) * 1996-06-28 1999-08-17 Hoffmann-La Roche Inc. Use of sulfonamides
DZ2376A1 (en) * 1996-12-19 2002-12-28 Smithkline Beecham Plc New sulfonamide derivatives process for their preparation and pharmaceutical compositions containing them.
JP2002511097A (en) * 1997-07-11 2002-04-09 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 5-HT (6) Sulfonamide derivative as a receptor antagonist and method for producing the same
GB9801392D0 (en) * 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
WO2000012623A3 (en) 2000-08-24
WO2000012623A2 (en) 2000-03-09
AU5970699A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
DE69909613D1 (en) Bicyclische hydroxamsäurederivate
DE69924108D1 (en) Offshore-bohrsystem
DE59912932D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE69918845D1 (en) Polyketonlösung
DE69913545D1 (en) Pyrimidonderivate
PL343923A1 (en) New use
DE69943409D1 (en) Fmcw-radar
DE69904335D1 (en) Aminomethylcarbonsäurederivate
EA199900308A3 (en) Swichgear
DE69914921D1 (en) Phenyl-xanthinderivate
DE69835235D1 (en) Thermoplastische silikonelastomere
DE59903023D1 (en) Perorale wirkstoff-suspension
DE59914151D1 (en) Arylalkanoylpyridazine
GB9818914D0 (en) Use
DE69908871D1 (en) Thermisch härtbare glasplatte
DE69934603D1 (en) Elektrophotographischer photoconduktor
GB9814640D0 (en) New use
DE69915628D1 (en) Ritonavir-polymorph
DE60042897D1 (en) Photovervielfacherröhre
DE69939823D1 (en) Endo-beta-n-acetylglukosaminidase
DE69938146D1 (en) Ptc-chip-thermistor
DE69905001D1 (en) Koagulationsvorrichtung
DE69904442D1 (en) Cyclohexandiol-derivate
DE69925859D1 (en) Cycloalkylsubstituierte aminomethylpyrrolidin-derivate
DE59904407D1 (en) Chromanderivate

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)